This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Tetmedical, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Roy Cohen: Innovator in Enzymatic Detection Technologies
Introduction
Roy Cohen is a notable inventor based in Cortland, NY (US). He has made significant contributions to the field of biomarker detection through his innovative patent. His work focuses on developing methods that utilize tethered enzymes for the detection of enzymatic activity in various applications.
Latest Patents
Roy Cohen holds a patent for an "Apparatus and methods using tethered enzymes for the detection of the enzymatic activity of biomarkers." This invention describes a coupled enzyme reaction point of care assay system that detects and measures an active enzyme biomarker from a patient's blood sample. The assay system includes a point of care blood collector for collecting blood into a vial. It features a biomarker detection mechanism with at least three fluid flow entities, including a test strip, a negative control strip, and a positive control strip. The reaction zones consist of various substrates, co-factors, buffers, cryoprotectants, and tethered enzymes, with at least one enzyme producing luminescence. A photonic luminescence reader measures the light emitted from the active enzyme biomarker present in the patient's blood.
Career Highlights
Roy Cohen's career is marked by his dedication to advancing medical diagnostics. His innovative approach to biomarker detection has the potential to improve patient outcomes by providing rapid and accurate results. He is currently associated with Tetmedical, Inc., where he continues to develop cutting-edge technologies in this field.
Collaborations
Throughout his career, Roy has collaborated with notable professionals, including David R. Fischell and Alexander J. Travis. These collaborations have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Roy Cohen's work in enzymatic detection technologies exemplifies the impact of innovation in medical diagnostics. His contributions are paving the way for more effective and efficient healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile